Background {#Sec1}
==========

The partial pressure of blood gases can be estimated through measurement of dissolved gases that diffuse to the skin surface \[[@CR1], [@CR2]\]. Measurement of transcutaneous PO~2~ (PtcO~2~) and PCO~2~ (PtcCO~2~) requires local heating of the skin, which dilates vessels and increases arterial blood supply to the skin capillary bed under the sensor, resulting in accelerated gas diffusion \[[@CR3], [@CR4]\]. In clinical practice, this method is widely used to assess pulmonary gas exchange function in infants and children, and in adults with acute or chronic respiratory failure \[[@CR5]--[@CR7]\]. It may also be applied to monitoring the condition of patients on mechanical ventilation and managing limb ischemia \[[@CR8]--[@CR10]\].

Although previous studies have investigated the relationship between PtcCO~2~ and PaCO~2~ over time, the time courses of transcutaneous data for the estimation of arterial blood gas analysis (BGA) are not well characterized \[[@CR11]--[@CR13]\]. Various factors may influence the time course of agreement including the response speed of the electromechanical gas measuring system, the speed of skin heating, and the time to equilibration of gases \[[@CR3], [@CR13]--[@CR15]\]. This information would allow physicians to choose a convenient (early) time-point for transcutaneous BGA for the estimation of arterial BGA and an optimal time-point for increased accuracy.

A previous study suggested that the correlation between arterial BGA and transcutaneous BGA data via sensors on the chest is stronger than that observed via sensors on the arm; however, this report involved only anesthetized adult patients \[[@CR16]\]. The most commonly recommended sensor location, according to the guidelines established by the American Association for Respiratory Care, is the upper chest followed by the lateral side of the abdomen, chest, buttock, inside of the upper thigh, forearm, the zygomatic bone, the ear lobe, cheek, or the forehead in neonates and small pediatric patients \[[@CR9]\]. In the beginning, we compared data obtained from sensors placed on the chest, forearm, earlobe, and forehead in spontaneously breathing adults. In the early stage of the study, we decided to use only a chest or forearm sensor (data are shown later).

Arterial blood samples are drawn with the patient being in a steady state \[[@CR17]\]. The usual clinical practice for arterial BGA in fully conscious patients involves a single arterial puncture performed after a waiting period of 20--30 min \[[@CR17], [@CR18]\]. The procedure of arterial puncture may cause pain and hyperventilation, thereby altering subsequent arterial BGA data due to respiratory alkalosis \[[@CR17]\]. In mechanically ventilated patients, the stability after a change in F~I~O~2~ is reached between 10 and 30 min depending on the physiological and pathophysiological conditions of the patient \[[@CR19]\]. Therefore, in the present study, the arterial BGA data with one-time arterial puncture after a waiting (resting) period of 30 min in the supine position was defined as the gold standard blood gas data.

We evaluated the transcutaneous BGA data at 1-min intervals comparing the final goal of arterial BGA at 30 min. This novel approach will answer the following questions: "From which time point are the transcutaneous BGA data meaningful?" and "How accurately are the current transcutaneous BGA data predicting arterial BGA?" In addition, the results of the subgroup analyses which may help to understand transcutaneous BGA, are shown. Finally, we discuss the most important subgroup (i.e., severe hypercapnia with PaCO~2~ \> 50 mmHg) and recommend a reasonable time-saving step for the accurate diagnosis of these patients.

Methods {#Sec2}
=======

Subjects and study procedures {#Sec3}
-----------------------------

The study was approved by the Ethics Committee of the International University of Health and Welfare (IUHW, approval number 13-B-109). All subjects provided written consent prior to participating in this study. All subjects were adults, aged ≥20 years. Both healthy volunteers and patients who visited the Department of Respiratory Medicine, IUHW Shioya Hospital were invited to participate in the study. Measurements were performed in the supine position at room temperature (24--25 °C). Transcutaneous BGA data from 1 to 30 min and arterial BGA data at 30 min were obtained, and compared through Bland--Altman analysis \[[@CR20]\]. Monitoring of percutaneous oxygen saturation (SpO~2~) with a pulse oximeter (PULSOX-C; KONICA MINOLTA, Osaka, Japan) was performed to confirm that SpO~2~ data from each subject were constant during the study (from sensor fixation to arterial blood sampling).

Transcutaneous BGA {#Sec4}
------------------

PtcO~2~ and PtcCO~2~ were measured with a transcutaneous gas monitoring system (TCM4 with tcSensor 84 for neonatal, pediatric and adult patients; Radiometer Medical AsP, Copenhagen, Denmark), using the principles of the Clark and Severinghaus electrodes \[[@CR21]\]. Calibration was achieved within 5--6 min. Following membrane change, the calibration required approximately 10 min. The temperature of the skin probe was set at 44 °C, as previously recommended \[[@CR3], [@CR8], [@CR9]\]. Measurements were performed in the supine position with the skin probe position on (i) the upper chest wall (left or right second intercostal space in the midclavicular line), (ii) the inside of the forearm (upper third of the inner surface of the left or the right forearm), (iii) the earlobe, or (iv) the forehead. The sensor location was randomized and the duration of measurements was ≥30 min. Prior to sensor fixation, the skin and electrode were thoroughly cleaned, and an adhesive ring with two drops of contact gel was applied, according to the instructions provided by the manufacturer. Chest hair was avoided, and depilation from the thoracic skin was not necessary. After sensor fixation, PtcO~2~ and PtcCO~2~ were recorded at 1-min intervals. Prior to sensor fixation, the sensor detected the atmospheric PO~2~ and PCO~2~. The electromechanical response of the TCM4 device, as shown by breathing on the sensor measuring atmospheric PO~2~ and PCO~2~, elicited a decrease in PO~2~ within 5 s and an increase in PCO~2~ within 15 s.

Arterial BGA {#Sec5}
------------

Arterial BGA was performed at 30 min after sensor fixation in the supine position. Femoral arterial blood (0.5--1.0 ml) was drawn with a 22-gauge needle attached to a heparinized syringe. Samples were immediately analyzed with a blood gas analyzer (Rapidlab 1265; Siemens Healthcare Diagnostics, Sudbury, United Kingdom).

Subgroup analysis {#Sec6}
-----------------

The effects of gender, age, PaCO~2~ level and PaO~2~ level on the agreement data were evaluated. The transcutaneous data obtained via the sensors on the chest or forearm were used. The subjects with a PaCO~2~ level within the normal range (35--45 mmHg) were compared with those having different levels of hypocapnia or hypercapnia \[[@CR17]\]. The subjects with a PaO~2~ level with the normal range (80--100 mmHg) were compared with those having hypoxemia or hyperoxemia \[[@CR17]\].

Data analysis {#Sec7}
-------------

Data are expressed as means ± standard deviation (SD), unless otherwise indicated. Concordance of arterial (at 30 min) and transcutaneous (between 1 and 30 min) blood gas data were investigated by Bland--Altman analysis. Therefore, 30 Bland--Altman analyses were performed. Analysis of variance with Tukey's correction or unpaired t-test (two-tailed) was used for the comparison at 30 min. The Excel Statistics software, 2010 version (Social Survey Research Information Co., Ltd., Tokyo, Japan) was used. *P* \< 0.05 denoted a statistically significant difference. Data were accumulated from the usual clinical practice at IUHW Shioya Hospital. When the number of subjects using chest or forearm sensor was 163 (males: 107, females: 56), PtcCO~2~ at 30 min was markedly larger than PaCO~2~ at 30 min (*P* = 3.8 × 10^− 42^). In the subgroup analysis, the absolute values of PO~2~ bias were larger in males than in females with *P* = 0.050. We calculated the necessary sample size to evaluate this interesting effect of gender. The expected effect size was 4.0 mmHg (SD: 12.1 mmHg); therefore, the standardized effect size was 0.33 \[[@CR22]\]. It was considered that approximately 100 samples per group were necessary for an 80% power to detect significance at the 10% level (two-sided) in a t-test. The number of subjects using a chest or forearm sensor increased to 272 (males: 168, females: 104). The *P*-value decreased to \< 0.01 and the effect of gender was confirmed (data are shown later).

Results {#Sec8}
=======

The tolerance of local heating for electrode attachment was good. There were no signs of skin irritation or erythema at the end of the monitoring.

Study population {#Sec9}
----------------

A total of 295 spontaneously breathing Asian adults (184 males, 111 females; mean age: 73.6 ± 14.5 years), comprising 10 healthy volunteers and 285 patients with various lung diseases, were enrolled from August 2015 to August 2019. The breakdown of lung diseases is shown in Supplementary Table S1 (Additional file [1](#MOESM1){ref-type="media"}). Forty-nine subjects received oxygen therapy. These subjects were studied while receiving supplemental O~2~. Initially, four sensor positions were randomly used. However, shortly after the study was initiated, the use of the forehead as a sensor location was discontinued because of prominently large biases (Fig. [1](#Fig1){ref-type="fig"}). The use of the earlobe as sensor location was also discontinued because of large biases (data shown later in this article). Age, gender, body mass index and diagnosed diseases were almost equally distributed among the four groups (one group per probe; Additional file [1](#MOESM1){ref-type="media"}, Supplementary Table S1). Monitored SpO~2~ was stable and constant (i.e., ≤ 2% change during the 30 min observation period in any subject). Fig. 1Process of data collection via the chest or forearm sensors

Agreement at 30 min {#Sec10}
-------------------

The concordances between transcutaneous BGA and arterial BGA data at 30 min are shown in Fig. [2](#Fig2){ref-type="fig"}. Transcutaneous data obtained via the chest or forearm sensors were used (*n* = 272). The bias of PCO~2~ was 4.7 mmHg, with PtcCO~2~ being higher than PaCO~2~, and the 95% limits of agreement were ± 6.3 mmHg (Fig. [2](#Fig2){ref-type="fig"}a). The bias of PO~2~ was 12.2 mmHg, with PaO~2~ being higher than PtcO~2~, and the 95% limits of agreement were ± 23.1 mmHg (Fig. [2](#Fig2){ref-type="fig"}b). Fig. 2Blood gas data at 30 min (transcutaneous data were obtained via the chest or forearm sensors, *n* = 272). **a** Concordance between PaCO~2~ and PtcCO~2~ data at 30 min. The bias of PCO~2~ was 4.7 mmHg, with PtcCO~2~ being higher than PaCO~2~ and 95% limits of agreement of ±6.3 mmHg. **b** Concordance between PaO~2~ and PtcO~2~ data at 30 min. The bias of PO~2~ was 12.2 mmHg, with PaO~2~ being higher than PtcO~2~ and 95% limits of agreement of ±23.1 mmHg

Time courses of agreement {#Sec11}
-------------------------

The time courses of the two indices used in the Bland--Altman analysis (the bias and the 95% limits of agreement) are shown in Fig. [3](#Fig3){ref-type="fig"}. This was a series of 30 Bland--Altman analyses in which we compared 1--30 min transcutaneous data with min-30 arterial BGA data. Transcutaneous data obtained via the chest or forearm sensors were used (*n* = 272). The bias of PCO~2~ was 0.2 mmHg at 4 min (Fig. [3](#Fig3){ref-type="fig"}a), and the 95% limits of agreement (± 1.96SD) were ± 13.6 mmHg (Fig. [3](#Fig3){ref-type="fig"}b). This 1.96SD for PCO~2~ was initially reduced; however, it was similar to that obtained between 12 and 30 min (6.3--7.5 mmHg). At 8 min or later, the bias was 4.1--4.8 mmHg, with PtcCO~2~ being higher than PaCO~2~. In contrast, the absolute value of bias of PO~2~ was lowest (almost 0 mmHg) at 1--2 min (Fig. [3](#Fig3){ref-type="fig"}c), and the 1.96SD was reduced over time, with the closest agreement observed at 30 min (± 23.1 mmHg) (Fig. [3](#Fig3){ref-type="fig"}d). Fig. 3Time courses of Bland-Altman analysis indices: the bias and 95% limits of agreement (transcutaneous data were obtained via the chest or forearm sensors, *n* = 272). Average data from 272 subjects are shown. **a** Bias and **b** 1.96SD on PCO~2~; **c** bias and **d** 1.96SD on PO~2~. The bias on PCO~2~ was 0.2 mmHg at 4 min (**a**), and subsequently increased to a plateau of 4.1--4.8 mmHg, which was almost stable between 8 and 30 min. 1.96SD on PCO~2~ declined over time, with the minimum (6.3 mmHg) observed at 30 min; however, it remained almost constant (6.3--7.5 mmHg) between 12 and 30 min, (**b**). The bias on PO~2~ initially decreased, passed the nadir at 5--6 min, and plateaued between 16 and 30 min (**c**). 1.96SD on PO~2~ decreased over time, with the minimum (23.1 mmHg) observed at 30 min (**d**)

Differences in agreement among four sensor locations {#Sec12}
----------------------------------------------------

The time courses of the agreement data were compared among the four sensor locations (Additional file [2](#MOESM2){ref-type="media"}, Supplementary Fig. S1). At 30 min, the absolute values of bias obtained via the forearm and chest sensors were equivalent, and significantly lower than those obtained via the earlobe or forehead sensors for both PCO~2~ and PO~2~ (Fig. [4](#Fig4){ref-type="fig"}). At 30 min, the absolute values of PO~2~ bias obtained via the earlobe sensor were significantly lower than those obtained via the forehead sensor. There was no significant difference in arterial BGA data or pulse oximeter data among the four different sensor location groups (Additional file [1](#MOESM1){ref-type="media"}, Supplementary Table S2). On the other hand, PtcO~2~ data obtained via the earlobe or forehead sensor at 30 min were significantly different from those obtained via the forearm or chest sensor at 30 min. Fig. 4Comparison of bias at 30 min among four sensor locations. The absolute values of bias obtained via forearm (*n* = 143) and chest (*n* = 129) sensors were equivalent, and were significantly lower than those obtained via the earlobe (*n* = 17) or forehead (*n* = 6) sensors for both PCO~2~ and PO~2~. The absolute values of PO~2~ bias obtained via the earlobe sensor were significantly lower than those obtained via the forehead. ANOVA with Tukey's pot-hoc test, \*: *P* \< 0.05, \*\*: *P* \< 0.01, Bars: SEM

Subgroup analyses {#Sec13}
-----------------

### Effects of gender and age {#Sec14}

The effects of gender on the time courses were examined: male (*n* = 168), female (*n* = 104, Additional file [2](#MOESM2){ref-type="media"}, Supplementary Fig. S2). At 30 min, the absolute values of PO~2~ bias in males were significantly larger than those recorded in females (*P* \< 0.01; Fig. [5](#Fig5){ref-type="fig"}a). The effects of age on the time courses were examined in the following four groups: 20--39 years (*n* = 11), 40--59 years (*n* = 12), 60--79 years (*n* = 138), and ≥ 80 years (*n* = 111) (Additional file [2](#MOESM2){ref-type="media"}, Supplementary Fig. S3). At 30 min, the PCO~2~ biases in young adults (20--39 years old) were significantly lower than those observed in the 40--59 year-old group and ≥ 80 year-old group (both *P* \< 0.05; Fig. [5](#Fig5){ref-type="fig"}b). Fig. 5Subgroup analyses on gender and age at 30 min. Transcutaneous data obtained via the chest or forearm sensors were used (*n* = 272). Bars: SEM, \*: *P* \< 0.05, \*\*: *P* \< 0.01. **a** Comparison of biases between males (*n* = 168) and females (*n* = 104). Gender had no significant effects on PCO~2~ bias. However, the absolute values of male PO~2~ bias observed were significantly larger than those of female PO~2~ bias (Unpaired t-test). **b** Comparison of biases among 4 age groups: 20--39 years (*n* = 11), 40--59 years (*n* = 12), 60--79 years (*n* = 138), and ≥ 80 years (*n* = 111). PCO~2~ biases in young adults (20--39 years) were significantly lower than in the 2 groups of 40--59 years and ≥ 80 years. However, there were no significant differences in PO~2~ bias among the four groups (ANOVA with Tukey's pot-hoc test)

### Effects of PaCO~2~ and PaO~2~ levels {#Sec15}

The effects of hypocapnia on the time courses were examined in the following two levels of PaCO~2~: PaCO~2~ \< 31 mmHg group (severe hypocapnia, *n* = 7) and 31 ≤ PaCO~2~ \< 35 mmHg group (mild hypocapnia, *n* = 24; Additional file [2](#MOESM2){ref-type="media"}, Supplementary Fig. S4). At 30 min, the absolute values of bias in the severe hypocapnia group were higher than those noted in the normal PaCO~2~ group (*n* = 202) for both PCO~2~ (*P* \< 0.01) and PO~2~ (*P* \< 0.05; Fig. [6](#Fig6){ref-type="fig"}a). This effect of hypocapnia on the PCO~2~ bias was dependent on severity. The effects of hypercapnia on the time courses were examined in the following two levels of PaCO~2~: 45 \< PaCO~2~ ≤ 50 mmHg group (mild hypercapnia, *n* = 26) and \> 50 mmHg group (severe hypercapnia, *n* = 13; Additional file [2](#MOESM2){ref-type="media"}, Supplementary Fig. S5). At 30 min, the PCO~2~ bias in the mild hypercapnia group was significantly lower than that observed in the normal PaCO~2~ group (*P* \< 0.01; Fig. [6](#Fig6){ref-type="fig"}b). The effects of the PaO~2~ level on the time courses were similarly examined (Additional file [2](#MOESM2){ref-type="media"}, Supplementary Fig. S6). At 30 min, the absolute values of bias in the hypoxemia group (*n* = 158) were lower than those measured in the normal PaO~2~ group (*n* = 102) for both PCO~2~ (*P* \< 0.05) and PO~2~ (*P* \< 0.01; Fig. [6](#Fig6){ref-type="fig"}c). At 30 min, the absolute values of PO~2~ bias in the hyperoxemia group (*n* = 12) were larger than those recorded in the normal PaO~2~ group (*P* \< 0.05; Fig. [6](#Fig6){ref-type="fig"}c). Fig. 6Subgroup analyses on PaCO~2~ level and PaO~2~ level at 30 min. Transcutaneous data obtained via the chest or forearm sensors were used (*n* = 272). Bars: SEM, \*: *P* \< 0.05, \*\*: *P* \< 0.01, ANOVA with Tukey's pot-hoc test. **a** Comparison of biases among severe hypocapnia (PaCO~2~ \< 31 mmHg, *n* = 7), mild hypocapnia (31 mmHg ≤ PaCO~2~ \< 35 mmHg, *n* = 24), and normal range (35 mmHg ≤ PaCO~2~ ≤ 45 mmHg, *n* = 202). The absolute values of bias observed in the severe hypocapnia group were significantly larger than those observed in the normal range group for both PCO~2~ and PO~2~. This effect of hypocapnia seemed to be intensity-dependent. **b** Comparison of biases among normal range (35 mmHg ≤ PaCO~2~ ≤ 45 mmHg, *n* = 202), mild hypercapnia (45 mmHg \< PaCO~2~ ≤ 50 mmHg, *n* = 26), and severe hypercapnia (50 mmHg \< PaCO~2~, *n* = 13). PCO~2~ biases in mild hypercapnia were significantly smaller than in normal range group. **c** Comparison of biases among hypoxemia (PaO~2~ \< 80 mmHg, *n* = 158), normal range (80 mmHg ≤ PaO~2~ ≤ 100 mmHg, *n* = 102), and hyperoxemia (100 mmHg \< PaO~2~, *n* = 12). The absolute values of bias observed in the hypoxemia group were significantly smaller than those observed in the normal range group for both PCO~2~ and PO~2~. The absolute values of PO~2~ bias observed in the hyperoxemia group were significantly larger than those observed in the normal range group. These effects on PO~2~ biases seemed to be PaO~2~ level-dependent

Precise observation of subjects with hypercapnia PaCO~2~ \> 50 mmHg {#Sec16}
-------------------------------------------------------------------

Data and profiles of subjects with hypercapnia (PaCO~2~ \> 50 mmHg, *n* = 13) are shown in Table [1](#Tab1){ref-type="table"}. Most of these subjects (85%) were receiving O~2~ therapy. At 4 min, PtcCO~2~ ≥ 50 mmHg was observed in 69% of these subjects. This ratio increased over time; at 12 min, all these subjects showed PtcCO~2~ ≥ 50 mmHg. At 13 min, all these subjects showed PtcCO~2~ ≥ 51 mmHg. Subjects with severe hypercapnia appeared to have more diseases (e.g., circulatory failure) than those with mild hypercapnia. Table 1Data and profiles of subjects with hypercapnia \> 50 mmHg (*n* = 13)No.AgeO~2~ therapy (L/min)PaCO~2~ (mmHg)PtcCO~2~ (mmHg)PaO~2~ (mmHg)PtcO~2~ (mmHg)CharacteristicsBlood pressure (mmHg)Body temperatureCirculatory failureEdemaat 30 minat 4 minat 10 minat 11 minat 12 minat 13 minat 30 minat 30 minat 30 min1762 (nasal)50.4535455565657111.698ACO130/78Normal (?)----2823 (nasal)51.7[4249]{.ul}5050515193.358ACO, pneumonia119/5335.3 °C----3841.5 (nasal)52.351575757565677.375ACO160/75Normal (?)----4811 (nasal)52.75255555454537953COPD (E), ILD128/59Normal (?)----562Room air53.74655565656565555OHS139/75Normal (?)----6653 (nasal)54.5[40]{.ul}555656575960.760OHS, HF112/5936.2 °C++7894 (face mask)55.7[334949]{.ul}51526250.550COPD (E)126/83Normal (?)----888Room air58.859666667676780.772COPD (E), HF, ILD81/40Normal (?)+±9791.5 (nasal)59.754626262616179.876COPD (E)135/88Normal (?)----10856 (face mask)61.161717168677287.964OHS, airway infection139/7337.3 °CSuspected--11811.25 (nasal)67.157727272717149.734COPD (E)119/81Normal (?)Suspected±12703 (face mask)67.35780818181778177ACO, HF135/6136.7 °C+--13825 (face mask)116.4508891929211274.967COPD (E), MOF90/4538.5 °C+++No skin eruption was seen in any subjects. It was difficult to predict hypercapnia by underlined PtcCO~2~ data. All hypercapnia subjects with PaCO~2~ \> 50 mmHg showed PtcCO~2~ ≥ 50 mmHg for until 12 min. All the transcutaneous blood gas analysis data were obtained via chest sensor or forearm sensor. *ACO* Asthma-chronic obstructive pulmonary disease (COPD) overlap, *COPD* Chronic obstructive pulmonary disease, *E* Emphysema, *HF* Heart failure, *ILD* Interstitial lung disease, *MOF* Multiple organ failure, *OHS* Obesity hypoventilation syndrome

Discussion {#Sec17}
==========

By comparing the agreement between minutely obtained transcutaneous BGA data and the final answer data of arterial BGA at 30 min, we obtained the following findings. Firstly, the sensors placed on the chest and forearm are equally preferred. Secondly, the method to predict PaCO~2~ at 30 min is to initially measure PtcCO~2~ at 4 min without bias, and observe PtcCO~2~ at 8 min or later considering a bias of 4--5 mmHg. Thirdly, although PtcCO~2~ is useful, it cannot completely replace the actual levels of PaCO~2~ due to occasional large PCO~2~ bias. Fourthly, the subgroup analyses showed that gender, younger age, PaCO~2~ levels, and PaO~2~ levels affected PO~2~ and/or PCO~2~ biases. Fifthly, a reasonable step to reach accurate diagnosis of PaCO~2~ \> 50 mmHg using transcutaneous BGA data was recommended. Finally, we showed that the prediction of PaO~2~ by PtcO~2~ was unrealistic in Asian adults.

Previously, it was reported that the 1.96SD between venous PCO~2~ and PaCO~2~ was 15.0 mmHg \[[@CR23]\]. Venous PCO~2~ is occasionally used as a surrogate with a bias of 5 mmHg. Our approach enabled to answer the question of "From which time point are the PtcCO~2~ data meaningful?" The answer is "From 4 min.", because the limits of agreement between PaCO~2~ and PtcCO~2~ at 4 min or later were ± 13.6 mmHg or narrower. Of note, they were narrower than the limit of agreement (± 15.0 mmHg) between PaCO~2~ and venous PCO~2~. By waiting longer, we can obtain more accurate PtcCO~2~ data for the estimation of PaCO~2~. Several studies have indicated that PtcCO~2~ is more accurate than end-tidal PCO~2~ as a surrogate measure of PaCO~2~ \[[@CR24]--[@CR28]\]. While 1.96SD data between end-tidal PCO~2~ and PaCO~2~ ranged from 6.9 to 14.4 mmHg, 1.96SD data between PtcCO~2~ and PaCO~2~ ranged from 4.6 to 10.4 mmHg. The PtcCO~2~ data at 12--13 min or later were within the acceptable clinical range of agreement for PtcCO~2~ (± 7.5 mmHg) recommended in the guideline of the American Association for Respiratory Care \[[@CR9]\].

As a whole, the prediction of PaCO~2~ is possible. It involves initial measurement of PtcCO~2~ at 4 min without bias, and observation of PtcCO~2~ at 8 min or later considering a bias of 4--5 mmHg. In a steady state, PtcCO~2~ is higher than PaCO~2~ because the former is an epidermal parameter which does not exclusively reflect arterial blood, and CO~2~ is produced by living epidermal cells \[[@CR7], [@CR29], [@CR30]\].

The 1.96SD between PtcO~2~ and PaO~2~ displayed a continual decline without an obvious plateau at 30 min. Even the minimal limit of agreement of ±24.0 mmHg at 30 min is not negligible in clinical practice. Therefore, PtcO~2~ is not an appropriate substitute for PaO~2~. Kesten et al. reported that the 90% response speed of PtcCO~2~ in this system was approximately three times faster than that of PtcO~2~ \[[@CR14]\]. The Krogh's constants of diffusion for O~2~ and CO~2~ in water and aqueous tissues may be important to understand the difference between these gases \[[@CR15]\]. In water and aqueous tissues, the Krogh's constant of diffusion for CO~2~ has been reported to be 20--25 times higher than that for O~2~.

A change in the baseline level with time is termed "drift" \[[@CR31]\]. The calibration was performed prior to measuring each subject according to the protocol provided by the manufacturer. The duration of the measurement was only 30--40 min per subject; therefore, the "drift" effect was considered negligible.

A few previous studies have investigated the relationship between PtcCO~2~ and PaCO~2~ over time \[[@CR11]--[@CR13]\]. Fuke et al. compared PaCO~2~ via an arterial catheter and PtcCO~2~ over time (*n* = 6), yielding evaluations of individual agreements \[[@CR11]\]. Excellent agreement over time was shown in three subjects. Both Cuvelier et al. \[[@CR12]\] and Storre et al. \[[@CR13]\] compared PaCO~2~ via an arterial catheter and PtcCO~2~ over time (*n* = 12 and *n* = 10, respectively), demonstrating parallel changes without any description of concordance over time. The present noninvasive study without arterial catheterization is in line with the actual clinical practice for spontaneously breathing patients, and provides data from a larger sample of subjects compared with previous studies \[[@CR11]--[@CR13]\]. The subgroup analyses revealed that gender and younger age affected the biases. Further investigation is necessary to confirm this observation. The absolute values of biases (for both PCO~2~ and PO~2~) were larger in the PaCO~2~ \< 31 mmHg group than in the normal group. Arterial vasoconstriction by hyperventilation may be involved in this phenomenon \[[@CR23]\]. If PaCO~2~ is low, the PCO~2~ bias may increase and underestimation of hyperventilation might occur. However, Bendjelid et al. reported that the PaCO~2~ level did not affect the PCO~2~ bias (*n* = 55, Caucasians 85%) \[[@CR32]\]. The absolute values of biases (for both PCO~2~ and PO~2~) were smaller in the hypoxemia group than in the normal group. Hypoxic vasodilation may be involved in this phenomenon \[[@CR33]\].

Another limitation of the study is that arterial BGA was performed only at 30 min. However, it is worth performing Bland--Altman analysis for the comparison of the single time point arterial BGA data with the minutely obtained transcutaneous data. All gas data were collected during a short period (30--40 min) in the steady state, which was validated by observations that SpO~2~ data were almost constant in each subject from the sensor fixation to the arterial blood sampling procedure. The effect of changing body position (e.g., from sitting to supine position) on PaCO~2~ has been reported to be smaller than that exerted on PaO~2~ \[[@CR34], [@CR35]\]. Bland and Altman compared data from two different peak flow meters which cannot be performed simultaneously \[[@CR20]\].

Correct diagnosis of severe hypercapnia with PaCO~2~ \> 50 mmHg is important to avoid CO~2~ narcosis. This technology of TCM4 with a Severinghaus electrode is useful in identifying subjects with PaCO~2~ \> 50 mmHg. By performing arterial BGA after detecting PtcCO~2~ ≥ 50 mmHg during an observation for 12 min, PaCO~2~ \> 50 mmHg can be accurately measured (without exceptions at least in our 13 subjects). We recommend this reasonable step for the efficient use of PtcCO~2~ data.

Conclusions {#Sec18}
===========

We compared the agreement between minutely obtained transcutaneous BGA data and the final answer data of arterial BGA at 30 min. The use of sensors on the chest and forearm is equally recommended. Although PtcCO~2~ is useful and can be used as a screening tool for severe hypercapnia, it cannot completely replace PaCO~2~. On the other hand, the prediction of PaO~2~ by PtcO~2~ was unrealistic in Asian adults. Consideration of gender, age, PaCO~2~ levels, and PaO~2~ levels may assist in improving the accuracy of estimation. Further investigations are needed to clarify the mechanisms of these factors that influence the biases. This approach may be of potential use to better understand transcutaneous BGA.

Supplementary information
=========================

 {#Sec19}

**Additional file 1: Supplementary Table S1.** Comparison of subjects among the four groups of different sensor locations. **Supplementary Table S2.** Comparison of blood gas data among the four groups of different sensor locations. **Additional file 2: Supplementary Fig. S1.** Comparison of the time course data among the four locations of sensors. Average data are shown. Blue line: forearm (*n* = 143), red line: chest (*n* = 129), green line: earlobe (*n* = 17), and purple line: forehead (*n* = 6). Trajectories of (**a**) bias and (**b**) 1.96SD on PCO~2~. Trajectories of (**c**) bias and (**d**) 1.96SD on PO~2~. (**a**): Compared with the forearm or chest sensors, the earlobe or forehead sensors yielded larger bias for PCO~2~ at 4 min or later. (**b**): 1.96SD on PCO~2~ was similar among the four locations. (**c**): The forearm and chest sensors showed almost the same time course of bias for PO~2~. The earlobe sensor yielded larger absolute values of bias, whereas the forehead sensor yielded much larger absolute values of bias. (**d**): 1.96SD of the forehead sensor was larger than that of the forearm or chest sensors. **Supplementary Fig. S2.** Comparison of the time course data (males vs. females, *n* = 272). Transcutaneous data obtained via the chest or forearm sensors were used. Average data are shown. Blue line: males (*n* = 168), red line: females (*n* = 104). Trajectories of (**a**) bias and (**b**) 1.96SD on PCO~2~. Trajectories of (**c**) bias and (**d**) 1.96SD on PO~2~. PCO~2~ bias was similar between the two groups (**a**). The 1.96SD of females on PCO~2~ was slightly lower than male (**b**). The absolute values of female PO~2~ bias was lower than that of males (**c**). 1.96SD on PO~2~ was not affected by gender (**d**). **Supplementary Fig. S3.** Comparison of the time course data (among four age groups, *n* = 272). Transcutaneous data obtained via the chest or forearm sensors were used. Average data are shown. Blue line: 20--39 years (*n* = 11), red line: 40--59 years (*n* = 12), green line: 60--79 years (*n* = 138), purple line: ≥ 80 (*n* = 111). Trajectories of (**a**) bias and (**b**) 1.96SD on PCO~2~. Trajectories of (**c**) bias and (**d**) 1.96SD on PO~2~. Crossing the 0 line at approximately 5 min (later than in the other three groups), PCO~2~ biases in young adults (20--39 years) was slightly lower than those of the other three groups (**a**). The 1.96SD of young adults (20--39 years) on PCO~2~ was slightly higher than that of the other three groups at 21 min or later (**b**). The absolute values of PO~2~ bias in 40--59 years group seemed a little larger than those of the other three groups at 13 min or later. (**c**). The 1.96SD of young adults (20--39 years) on PO~2~ was slightly higher than that of the other three groups at 11 min or later (**d**). **Supplementary Fig. S4.** Comparison of the time course data to evaluate effects of hypocapnia. Transcutaneous data obtained via the chest or forearm sensors were used. Average data are shown. Blue line: severe hypocapnia (PaCO~2~ \< 31 mmHg, *n* = 7), red line: mild hypocapnia (31 mmHg ≤ PaCO~2~ \< 35 mmHg, *n* = 24), green line: normal range (35 mmHg ≤ PaCO~2~ ≤ 45 mmHg, *n* = 202). Trajectories of (**a**) bias and (**b**) 1.96SD on PCO~2~. Trajectories of (**c**) bias and (**d**) 1.96SD on PO~2~. Crossing the 0 line at 2--3 min (earlier than in the other two groups), PCO~2~ biases in severe hypocapnia group was larger than those of the other two groups (**a**). This effect of hypocapnia seemed to be severity-dependent at 9 min or later. The 1.96SD of severe hypocapnia group was higher than that of the other two groups (**b, d**). The absolute values of PO~2~ bias in severe hypocapnia group were larger than those of the other two groups at 6 min or later. (**c**). **Supplementary Fig. S5.** Comparison of the time course data to evaluate effects of hypercapnia. Transcutaneous data obtained via the chest or forearm sensors were used. Average data are shown. Blue line: normal range (35 mmHg ≤ PaCO~2~ ≤ 45 mmHg, *n* = 202), red line: mild hypercapnia (45 mmHg \< PaCO~2~ ≤ 50 mmHg, *n* = 26), green line: severe hypercapnia (50 mmHg \< PaCO~2~, *n* = 13). Trajectories of (**a**) bias and (**b**) 1.96SD on PCO~2~. Trajectories of (**c**) bias and (**d**) 1.96SD on PO~2~. Crossing the 0 line at about 6 min (later than normal range group), PCO~2~ biases in mild hypocapnia group were smaller than those of normal range group (**a**). This delay of crossing the 0 line seemed to be severity-dependent. The 1.96SD of severe hypercapnia group on PCO~2~ was higher than that of the other two groups (**b**). The absolute values of PO~2~ bias in mild hypercapnia group were smaller than those of normal range group at 2 min or later (**c**). 1.96SD on PO~2~ seemed to be about the same among the three groups (**d**). **Supplementary Fig. S6.** Comparison of the time course data to evaluate effects of PaO~2~ levels. Transcutaneous data obtained via the chest or forearm sensors were used. Average data are shown. Blue line: hypoxemia (PaO~2~ \< 80 mmHg, *n* = 158), red line: normal range (80 mmHg ≤ PaO~2~ ≤ 100 mmHg, *n* = 102), green line: hyperoxemia (100 mmHg \< PaO~2~, *n* = 12). Trajectories of (**a**) bias and (**b**) 1.96SD on PCO~2~. Trajectories of (**c**) bias and (**d**) 1.96SD on PO~2~. PCO~2~ biases in hypoxemia group were smaller than those of the other two groups (**a**). The 1.96SD on PCO~2~ seemed to be about the same among the three groups (**b**). The absolute values of PO~2~ bias in hypoxemia group were smaller than those of normal range group (**c**). The absolute values of PO~2~ bias in hyperoxemia group were larger than those of normal range group (**c**). The 1.96SD of hyperoxemia group on PO~2~ was higher than that of the other two groups (**d**).
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